Home / Guanfacine / United States
US ATC C02AC02 · updated 2 Nov 2026
Guanfacine shortage in United States
Is there a Guanfacine shortage in United States?
Yes. As of 2 Nov 2026, 4 Guanfacine products are reported short in United States, the first since 13 Nov 2025. No return date has been given. Main reason: not stated.
Also short in Spain, Australia. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Guanfacine Hydrochloride, Tablet, Extended Release, 1 mg (NDC 0228-2850-11) discontinuation | Actavis Pharma, Inc. | 13 Nov 2025 | not given | Not stated |
| US | Guanfacine Hydrochloride, Tablet, Extended Release, 2 mg (NDC 0228-2851-11) discontinuation | Actavis Pharma, Inc. | 13 Nov 2025 | not given | Not stated |
| US | Guanfacine Hydrochloride, Tablet, Extended Release, 3 mg (NDC 0228-2853-11) discontinuation | Actavis Pharma, Inc. | 13 Nov 2025 | not given | Not stated |
| US | Guanfacine Hydrochloride, Tablet, Extended Release, 4 mg (NDC 0228-2855-11) discontinuation | Actavis Pharma, Inc. | 13 Nov 2025 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).